Cargando…
FAM83H‐AS1 is a noncoding oncogenic driver and therapeutic target of lung adenocarcinoma
BACKGROUND: Little is known about noncoding oncogenes of lung adenocarcinoma (LUAD), and these potential drivers might provide novel therapeutic targets. METHODS: Since abnormally overexpression of oncogenic drivers is induced by genomic variation, we here utilized genomic, transcriptomic, and clini...
Autores principales: | Wang, Siwei, Han, Chencheng, Liu, Tongyan, Ma, Zhifei, Qiu, Mantang, Wang, Jie, You, Qingjun, Zheng, Xiufen, Xu, Weizhang, Xia, Wenjia, Xu, Youtao, Hu, Jingwen, Xu, Lin, Yin, Rong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7882096/ https://www.ncbi.nlm.nih.gov/pubmed/33634993 http://dx.doi.org/10.1002/ctm2.316 |
Ejemplares similares
-
Four transcription profile–based models identify novel prognostic signatures in oesophageal cancer
por: Liu, Tongyan, et al.
Publicado: (2019) -
FAM83A and FAM83A-AS1 both play oncogenic roles in lung adenocarcinoma
por: Wang, Gaoming, et al.
Publicado: (2021) -
Long Noncoding RNA SBF2-AS1 Is Critical for Tumorigenesis of Early-Stage Lung Adenocarcinoma
por: Chen, Rui, et al.
Publicado: (2019) -
Stereotactic ablative radiotherapy versus lobectomy for stage I non‐small cell lung cancer: A systematic review
por: Wang, Siwei, et al.
Publicado: (2018) -
Energy stress-induced circZFR enhances oxidative phosphorylation in lung adenocarcinoma via regulating alternative splicing
por: Ma, Zhifei, et al.
Publicado: (2023)